The screening visit (V1, day −3 to 0) will involve confirmation of eligibility, informed written consent, anamnesis, an ECG, a physical exam, and a blood sample for lithium level measurement.
Cellular drug effects will be studied, using lithium-mediated growth inhibition that will be correlated to clinical response and gene expression profiling in LCLs from the patient sample characterized for lithium response and control individuals.
The electrochemical performance of the pristine LMR NMC and corresponding F-doped samples as cathodes for Lithium ion Batteries (LIBs) are investigated by galvanostatic charge-discharge cycling and impedance spectroscopy.
The electrochemical performances of these samples as anode materials for lithium ion batteries are investigated by galvanostatic charge discharge method.
Li1+x(Ni0.37Mn0.63)1−xO2 (x = 0.123, 0.111, 0.086, 0.070, 0.031) cathode materials were synthesized via coprecipitation of carbonates and the samples with long lifespan for lithium ion batteries were obtained through adjusting the content of lithium.
Finally, optimized conductivity has been obtained for the sample with x = 0.3 for lithium ion battery: the total ionic conductivity reaches a maximum of about 4.16 × 10−4 S cm−1 at 30 °C with an activation energy of about 0.48 eV.
For sample fusion, lithium metaborate (LiBO2) was acquired from Acros Organics (99% purity; Lot # A0317552).
Prolonged treatment (~10 days) with very dilute solutions (~0.005 M) was used to produce the lithium-inserted samples for analytical experiments.
Meanwhile, CoO samples demonstrated much better cyclability and rate capability than Co3O4 samples, as they exhibited much higher coulombic efficiency and lower hysteresis for lithium insertion/extration.
Sample gained at 800 °C exhibits the best electrochemical property for lithium ion batteries.
